chr5-177600225-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_007255.3(B4GALT7):c.15G>A(p.Arg5Arg) variant causes a synonymous change. The variant allele was found at a frequency of 0.00000502 in 1,394,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000040 ( 0 hom. )
Consequence
B4GALT7
NM_007255.3 synonymous
NM_007255.3 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 5.10
Publications
0 publications found
Genes affected
B4GALT7 (HGNC:930): (beta-1,4-galactosyltransferase 7) This gene is a member of the beta-1,4-galactosyltransferase (beta4GalT) family. Family members encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose. Each beta4GalT member has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus which then remains uncleaved to function as a transmembrane anchor. The enzyme encoded by this gene attaches the first galactose in the common carbohydrate-protein linkage (GlcA-beta1,3-Gal-beta1,3-Gal-beta1,4-Xyl-beta1-O-Ser) found in proteoglycans. This enzyme differs from other beta4GalTs because it lacks the conserved Cys residues found in beta4GalT1-beta4GalT6 and it is located in cis-Golgi instead of trans-Golgi. Mutations in this gene have been associated with the progeroid form of Ehlers-Danlos syndrome. [provided by RefSeq, Oct 2009]
B4GALT7 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndrome, spondylodysplastic type, 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
- Ehlers-Danlos syndrome, spondylodysplastic typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 5-177600225-G-A is Benign according to our data. Variant chr5-177600225-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1588374.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B4GALT7 | NM_007255.3 | c.15G>A | p.Arg5Arg | synonymous_variant | Exon 1 of 6 | ENST00000029410.10 | NP_009186.1 | |
B4GALT7 | XM_047416681.1 | c.-1096G>A | 5_prime_UTR_variant | Exon 1 of 7 | XP_047272637.1 | |||
B4GALT7 | XM_047416682.1 | c.-381G>A | 5_prime_UTR_variant | Exon 1 of 7 | XP_047272638.1 | |||
B4GALT7 | XM_047416680.1 | c.-2261G>A | upstream_gene_variant | XP_047272636.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152034Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
152034
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000143 AC: 1AN: 69956 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
69956
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000402 AC: 5AN: 1242334Hom.: 0 Cov.: 30 AF XY: 0.00000164 AC XY: 1AN XY: 608770 show subpopulations
GnomAD4 exome
AF:
AC:
5
AN:
1242334
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
608770
show subpopulations
African (AFR)
AF:
AC:
1
AN:
25708
American (AMR)
AF:
AC:
0
AN:
22920
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
21312
East Asian (EAS)
AF:
AC:
3
AN:
27528
South Asian (SAS)
AF:
AC:
0
AN:
61278
European-Finnish (FIN)
AF:
AC:
0
AN:
29792
Middle Eastern (MID)
AF:
AC:
0
AN:
3576
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1000020
Other (OTH)
AF:
AC:
1
AN:
50200
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152146Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74370 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
152146
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74370
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41554
American (AMR)
AF:
AC:
0
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5162
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10566
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
1
AN:
67950
Other (OTH)
AF:
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Benign:1
Dec 22, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.